...
首页> 外文期刊>Asian Journal of Pharmaceutical and Clinical Research >INVESTIGATION AND OPTIMIZATION OF FORMULATION PARAMETERS FOR SELFNANOEMULSIFYING DELIVERY SYSTEM OF TWO LIPOPHILIC AND GASTROINTESTINAL LABILE DRUGS USING BOX-BEHNKEN DESIGN
【24h】

INVESTIGATION AND OPTIMIZATION OF FORMULATION PARAMETERS FOR SELFNANOEMULSIFYING DELIVERY SYSTEM OF TWO LIPOPHILIC AND GASTROINTESTINAL LABILE DRUGS USING BOX-BEHNKEN DESIGN

机译:盒形设计设计和优化两个脂联和胃肠道药丸的自成胶递送系统的配方参数

获取原文

摘要

Objective: Present research work aims toward codelivery of two hydrophobic drugs, curcumin (CRM) and duloxetine hydrochloride (DXH) through self-nanoemulsifying drug delivery systems (SNEDDS). Methods: Initially, binary mixture in the ratio of 1:1 was prepared and then loaded into SNEDDS. Box-Behnken design (BBD) was adopted to develop SNEDDS. As per the optimal design, 13 SNEDDS prototypes were prepared. Castor oil, tween-80 and Transcutol P? were used as oil, surfactant, and cosurfactant, respectively. To 1 mL of SNEDDS, 30 mg each of CRM and DXH was loaded (CRM-DXH- SNEDDS). Results: The design revealed that for mean droplet size, polydispersity index (PDI), as well as percentage drug loading, all the three factors, i.e. ratio of oil (a), surfactant (b), and cosurfactant (c) were found to give significant effect. Factor B showed the most significant effect on mean droplet size (y1). In case of PDI (y2), factors B and C exerted maximum influence, whereas, Factor A has shown non-significant effect. For percentage drug loading of drugs (y3 and y4), all the three factors were found to have the most significant effect. The optimized batch of CRM-DXH- SNEDDS having composition castor oil, tween-80, and Transcutol P? in the ratio: 2.17:5.22:2.61, revealed that the mean drug loading (%) of CRM and DXH in an optimized batch of SNEDDS was found to be 87.22±1.87 and 92.32±0.19%, respectively. The mean droplet size, PDI, and zeta potential of formed SNEDDS were observed as 113.14±1.14 nm, 0.20±0.026, and ?13.2 mV, respectively. Conclusion: BBD provided optimal formula composition for SNEDDS for obtaining desirable drug loading, emulsion droplet size, and zeta potential.
机译:目的:目前的研究工作旨在通过自乳化药物递送系统(SNEDDS)共同递送两种疏水性药物姜黄素(CRM)和盐酸度洛西汀(DXH)。方法:首先,制备比例为1:1的二元混合物,然后将其加载到SNEDDS中。采用Box-Behnken设计(BBD)来开发SNEDDS。根据最佳设计,准备了13个SNEDDS原型。蓖麻油,吐温80和Transcutol P?分别用作油,表面活性剂和助表面活性剂。向1 mL SNEDDS中分别装入30 mg CRM和DXH(CRM-DXH-SNEDDS)。结果:设计表明,对于平均液滴尺寸,多分散指数(PDI)以及载药量百分比,发现所有三个因素,即油(a),表面活性剂(b)和助表面活性剂(c)的比例均达到产生明显的效果。因子B对平均液滴尺寸(y1)表现出最显着的影响。在PDI(y2)的情况下,因子B和C发挥了最大的影响,而因子A则显示了不显着的影响。对于药物的载药量百分比(y3和y4),发现所有三个因素的影响最为显着。具有蓖麻油,吐温80和Transcutol P?的成分的CRM-DXH-SNEDDS的优化批次。比率为2.17:5.22:2.61,表明优化批次的SNEDDS中CRM和DXH的平均载药量(%)分别为87.22±1.87和92.32±0.19%。观察到形成的SNEDDS的平均液滴尺寸,PDI和ζ电势分别为113.14±1.14nm,0.20±0.026和≤13.2mV。结论:BBD为SNEDDS提供了最佳的配方组成,以获得理想的载药量,乳剂液滴大小和zeta电位。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号